Keystone Financial Planning’s Medtronic MDT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
– Sell
-126,411
Closed -$9.9M – 40
2026
Q2
$9.9M Buy
+126,411
New +$10.2M 2.55% 9
2023
Q2
– Sell
-10,754
Closed -$867K – 49
2023
Q1
$867K Buy
10,754
+1,151
+12% +$93.8K 0.3% 38
2022
Q4
$746K Buy
+9,603
New +$778K 0.25% 37

Other funds holding MDT

Keystone Financial Planning's MDT Position: Q3 2026 in Review

Keystone Financial Planning sold out of Medtronic (MDT) in Q3 2026, closing a stake of 126,411 shares — an estimated $9.9M sold.

Keystone Financial Planning first reported a position in MDT in Q4 2022 and held it in 3 quarters. The position peaked at $9.9M in Q2 2026. 697 funds tracked by Wall St. Rank hold MDT as of Q3 2026.

  • Keystone Financial Planning reported no remaining Medtronic position as of Q3 2026 after selling out during the quarter.
  • Keystone Financial Planning sold 126,411 Medtronic shares in Q3 2026, an estimated $9.9M.
  • Keystone Financial Planning first reported a position in Medtronic in Q4 2022 and held it in 3 quarters.
  • Keystone Financial Planning's Medtronic position peaked at $9.9M in Q2 2026.
  • 697 funds tracked by Wall St. Rank held Medtronic as of Q3 2026.

Based on Keystone Financial Planning's 13F filing for Q3 2026, filed 8 Oct 2026.